No reports of blood clotting linked to AstraZeneca vaccine in Jordan

Administration is reviewing all reports and sharing them with the specialised scientific committees

  

AMMAN — The Jordan Food and Drug Administration (JFDA) on Wednesday said that it has, so far, received no reports of blood clots in people who have received AstraZeneca’s coronavirus vaccine.

JFDA Director General Nizar Muhaidat said that all vaccine-related reports are “nothing but common and expected side effects”, including fatigue, muscle and joint pain, chills, fever, headache and nausea, according to the Jordan News Agency, Petra.

The administration is reviewing all reports and sharing them with the specialised scientific committees.

© Copyright The Jordan Times. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Health